Cellectis SA (CLLS) Stock Statistics & Valuation Metrics

Cellectis SA has a market cap or net worth of $267.60M. The enterprise value is $341.14M.

Cellectis SA has 72,325,455 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cellectis SA’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -16.67%.

The current PE Ratio of Cellectis SA is ―. Cellectis SA’s PEG ratio is -0.11.

In the last 12 months, Cellectis SA had revenue of 72.95M and earned -67.59M in profits. Earnings per share was -0.68.

In the last 12 months, operating cash flow was -37.91M and capital expenditures -2.23M, giving a free cash flow of -40.14M billion.

Cellectis SA pays an annual dividend of ―, resulting in a dividend yield of ―

Cellectis SA upcoming earnings date is Jul 30, 2026, TBA (Confirmed).

Cellectis SA as a current ratio of 1.62, with Debt / Equity ratio of 181.25%

In the past 12 months, Cellectis SA has paid -423.00K in taxes.

Cellectis SA EV to EBITDA ratio is -13.59, with an EV/FCF ratio of -12.74.

Cellectis SA has $185.66M in cash and marketable securities with $108.60M in debt, giving a net cash position of $77.06M billion.

Gross margin is 78.86%, with operating margin of -45.34%, and net profit margin of -92.66%.

The average price target for Cellectis SA is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy